About

Linda Zurkinden-Erismann, a Swiss lawyer and entrepreneur, is the founder and CEO of StiftungsZentrum.ch GmbH and partner at ZURKINDEN + PARTNER, specializing in legal, economic, and real estate advisory services. She has extensive governance experience, serving as General Manager of the Staub Kaiser Foundation, President of the Ferenc Mako Foundation, and board member of the Foundation for Inclusion and Community. At HMCare, Linda contributes her expertise in governance, foundations, and social impact strategy.

Colm Walsh, MBA, has over 20 years of experience in the textiles and supply chain industry, with leadership roles across Europe, Asia, and Latin America. As founder of 3SIXTY, he pioneered sustainable textiles made from recycled plastics and ocean waste. He has also led business development at Poplar Linens, negotiating with major retailers such as Tesco, Asda, and Sainsbury’s. As an active investor and advisor, Colm brings expertise in business strategy, supply chain management, and market expansion to HMCare’s board.

Dan Staner is a global life sciences executive with more than 30 years of senior leadership experience. He served as Vice President and General Manager for Moderna in Europe and the Middle East, where he oversaw multi-billion-dollar operations and led Moderna’s pandemic response strategy. Earlier, he held senior roles at Eli Lilly, managing regions from Switzerland to the Middle East. Currently Chief Business Officer at Alcediag, Dan brings unmatched expertise in commercialization, partnerships, and scaling healthcare innovations internationally.

Dr. Sacha Sidjanski, studied biology in Geneva, worked on infectious diseases at the Swiss Tropical Institute (Basel, CH) and at New York University (NYU, USA), followed by two post-doctoral works at SUNY (State University of New York) and at Pasteur Institute (France); he then joined the World Health Organization (WHO) at the end of 1999 as a ‘scientific officer’.

Since June 2006, Dr Sidjanski works as External Relations Manager at the School of Life Sciences at EPFL which is the home of four institutes -the Global Health Institute, the Brain & Mind Institute, -Swiss Institute for Experimental Cancer Research, and the Institute of Bioengineering. The School of Life Sciences has more than a thousand collaborators.

Sacha was also involved in a not-for-profit foundation, Innovative Medicines for Tuberculosis (iM4TB) pro bono based in the Innovation Park on the EPFL campus.

In 2016, Sacha and a team received the Challenge Debiopharm-Inartis for an innovative project, the Hello Mask Project, in the field of healthcare targeting physical and moral comfort of patients.

Born on 20 July 1964 in Geneva, Christophe holds a degree in commercial and industrial sciences, with a specialization in business management, University of Geneva, 1989.

Senior Auditor from 1991 to 1995 at Price Waterhouse Geneva, he joined Cartier / High Jewelry House as CFO/COO until 2008. In 2009, he became head of the High Jewelry division at Chopard.

In 2011 Christophe became CEO of Genève-Servette Hockey Club (GSHC), which he left in 2016 leaving a club with solid financial foundations.

After a mandate as Secretary General in a Swiss private bank, Christophe was recalled to the management of the GSHC in 2018 for 2 years, before taking the general management of a company specializing in ecofriendly construction for nearly three years. He moved from that position to a role of CEO and shareholder of a development company involved in sport infrastructure and real estate development in Valais.

In addition to his involvement in the HM Care project, Christophe currently holds various mandates and sits on several boards of directors.

Dr. Sacha Sidjanski, studied biology in Geneva, worked on infectious diseases at the Swiss Tropical Institute (Basel, CH) and at New York University (NYU, USA), followed by two post-doctoral works at SUNY (State University of New York) and at Pasteur Institute (France); he then joined the World Health Organization (WHO) at the end of 1999 as a ‘scientific officer’.

Since June 2006, Dr Sidjanski works as External Relations Manager at the School of Life Sciences at EPFL which is the home of four institutes -the Global Health Institute, the Brain & Mind Institute, -Swiss Institute for Experimental Cancer Research, and the Institute of Bioengineering. The School of Life Sciences has more than a thousand collaborators.

Sacha was also involved in a not-for-profit foundation, Innovative Medicines for Tuberculosis (iM4TB) pro bono based in the Innovation Park on the EPFL campus.

In 2016, Sacha and a team received the Challenge Debiopharm-Inartis for an innovative project, the Hello Mask Project, in the field of healthcare targeting physical and moral comfort of patients.

For 10 years, he held various senior positions as Director and global Vice-President of Research and Development with US companies, including California-based DJO Inc. In 2009, he left the industry to create the EssentialMed Foundation, which aims to make access to medical technology universal by developing and deploying high quality, affordable devices for the developing world. In 2011, Klaus joined the EPFL to initiate and lead EssentialTech, a programme with the same goal, which expanded to more technology domains.

​